Annual EBITDA
-$2.02 M
+$3.40 M+62.72%
September 1, 2024
Summary
- As of February 23, 2025, DRUG annual EBITDA is -$2.02 million, with the most recent change of +$3.40 million (+62.72%) on September 1, 2024.
- During the last 3 years, DRUG annual EBITDA has risen by +$4.93 million (+70.93%).
- DRUG annual EBITDA is now -472.06% below its all-time high of -$353.20 thousand, reached on September 30, 2020.
Performance
DRUG EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$1.14 M
-$576.10 K-101.80%
December 1, 2024
Summary
- As of February 23, 2025, DRUG quarterly EBITDA is -$1.14 million, with the most recent change of -$576.10 thousand (-101.80%) on December 1, 2024.
- Over the past year, DRUG quarterly EBITDA has increased by +$92.70 thousand (+7.51%).
- DRUG quarterly EBITDA is now -718.30% below its all-time high of $184.70 thousand, reached on June 1, 2024.
Performance
DRUG Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$1.92 M
+$92.70 K+4.60%
December 1, 2024
Summary
- As of February 23, 2025, DRUG TTM EBITDA is -$1.92 million, with the most recent change of +$92.70 thousand (+4.60%) on December 1, 2024.
- Over the past year, DRUG TTM EBITDA has increased by +$3.05 million (+61.30%).
- DRUG TTM EBITDA is now -7981.93% below its all-time high of -$23.80 thousand, reached on December 31, 2019.
Performance
DRUG TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
DRUG EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +62.7% | +7.5% | +61.3% |
| 3 y3 years | +70.9% | +7.5% | +61.3% |
| 5 y5 years | -472.1% | +7.5% | +61.3% |
DRUG EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +82.8% | -718.3% | +70.2% | at high | +84.8% |
| 5 y | 5-year | -472.1% | +82.8% | -718.3% | +70.2% | -7981.9% | +84.8% |
| alltime | all time | -472.1% | +82.8% | -718.3% | +70.2% | -7981.9% | +84.8% |
Bright Minds Biosciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | -$1.14 M(+101.8%) | -$1.92 M(-4.6%) |
| Sep 2024 | -$2.02 M(-62.7%) | -$565.90 K(-406.4%) | -$2.02 M(-23.0%) |
| Jun 2024 | - | $184.70 K(-146.1%) | -$2.62 M(-32.3%) |
| Mar 2024 | - | -$400.30 K(-67.6%) | -$3.87 M(-22.2%) |
| Dec 2023 | - | -$1.23 M(+5.7%) | -$4.97 M(-8.2%) |
| Sep 2023 | -$5.42 M(-53.7%) | -$1.17 M(+9.9%) | -$5.41 M(-17.3%) |
| Jun 2023 | - | -$1.06 M(-29.3%) | -$6.55 M(-13.5%) |
| Mar 2023 | - | -$1.50 M(-10.4%) | -$7.57 M(-21.1%) |
| Dec 2022 | - | -$1.68 M(-27.1%) | -$9.60 M(-18.3%) |
| Sep 2022 | -$11.72 M | -$2.30 M(+10.5%) | -$11.75 M(-0.5%) |
| Jun 2022 | - | -$2.08 M(-41.0%) | -$11.80 M(-7.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$3.53 M(-7.7%) | -$12.69 M(+22.2%) |
| Dec 2021 | - | -$3.83 M(+62.5%) | -$10.38 M(+47.7%) |
| Sep 2021 | -$6.95 M(+1867.6%) | - | - |
| Sep 2021 | - | -$2.36 M(-20.7%) | -$7.03 M(+41.4%) |
| Jun 2021 | - | -$2.97 M(+142.1%) | -$4.97 M(+145.1%) |
| Mar 2021 | - | -$1.23 M(+159.0%) | -$2.03 M(+151.8%) |
| Dec 2020 | - | -$473.60 K(+59.0%) | -$805.10 K(+126.6%) |
| Sep 2020 | -$353.20 K | - | - |
| Sep 2020 | - | -$297.90 K(+927.2%) | -$355.30 K(+519.0%) |
| Jun 2020 | - | -$29.00 K(+530.4%) | -$57.40 K(+102.1%) |
| Mar 2020 | - | -$4600.00(-80.7%) | -$28.40 K(+19.3%) |
| Dec 2019 | - | -$23.80 K | -$23.80 K |
FAQ
- What is Bright Minds Biosciences annual EBITDA?
- What is the all time high annual EBITDA for Bright Minds Biosciences?
- What is Bright Minds Biosciences annual EBITDA year-on-year change?
- What is Bright Minds Biosciences quarterly EBITDA?
- What is the all time high quarterly EBITDA for Bright Minds Biosciences?
- What is Bright Minds Biosciences quarterly EBITDA year-on-year change?
- What is Bright Minds Biosciences TTM EBITDA?
- What is the all time high TTM EBITDA for Bright Minds Biosciences?
- What is Bright Minds Biosciences TTM EBITDA year-on-year change?
What is Bright Minds Biosciences annual EBITDA?
The current annual EBITDA of DRUG is -$2.02 M
What is the all time high annual EBITDA for Bright Minds Biosciences?
Bright Minds Biosciences all-time high annual EBITDA is -$353.20 K
What is Bright Minds Biosciences annual EBITDA year-on-year change?
Over the past year, DRUG annual EBITDA has changed by +$3.40 M (+62.72%)
What is Bright Minds Biosciences quarterly EBITDA?
The current quarterly EBITDA of DRUG is -$1.14 M
What is the all time high quarterly EBITDA for Bright Minds Biosciences?
Bright Minds Biosciences all-time high quarterly EBITDA is $184.70 K
What is Bright Minds Biosciences quarterly EBITDA year-on-year change?
Over the past year, DRUG quarterly EBITDA has changed by +$92.70 K (+7.51%)
What is Bright Minds Biosciences TTM EBITDA?
The current TTM EBITDA of DRUG is -$1.92 M
What is the all time high TTM EBITDA for Bright Minds Biosciences?
Bright Minds Biosciences all-time high TTM EBITDA is -$23.80 K
What is Bright Minds Biosciences TTM EBITDA year-on-year change?
Over the past year, DRUG TTM EBITDA has changed by +$3.05 M (+61.30%)